Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19

Abe, 1980, Use of FOY-305 for the treatment of pain attacks associated with chronic pancreatitis, New Horiz. Med., 12, 233 Baig, 2016, Computer Aided Drug Design: Success and Limitations, Curr. Pharm. Des., 22, 572, 10.2174/1381612822666151125000550 Baig, 2019, Multi-Spectroscopic Characterization of Human Serum Albumin Binding with Cyclobenzaprine Hydrochloride: Insights from Biophysical and In Silico Approaches, Int. J. Mol. Sci., 20, 662, 10.3390/ijms20030662 Baig, 2014, Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study, PLoS ONE, 9, e112456, 10.1371/journal.pone.0112456 Bao, 2018, Discover potential inhibitors for PFKFB3 using 3D-QSAR, virtual screening, molecular docking and molecular dynamics simulation, J. Recept. Signal Transduct. Res., 38, 413, 10.1080/10799893.2018.1564150 Berendsen, 1984, Molecular dynamics with coupling to an external bath, J. Chem. Phys., 81, 3684, 10.1063/1.448118 Bestle, 2020, TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells, Life Sci. Alliance, 3, e202000786, 10.26508/lsa.202000786 Bjelkmar, 2010, Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models, J. Chem. Theory Comput., 6, 459, 10.1021/ct900549r Breining, 2021, Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety, Basic Clin. Pharmacol. Toxicol., 128, 204, 10.1111/bcpt.13533 Breining, 2021, Camostat mesylate against SARS-CoV-2 and COVID-19—Rationale, dosing and safety, Basic Clin. Pharmacol. Toxicol., 128, 204, 10.1111/bcpt.13533 Chen, 2010, TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells, Am. J. Pathol., 176, 2986, 10.2353/ajpath.2010.090665 Darden, 1993, Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems, J. Chem. Phys., 98, 10089, 10.1063/1.464397 Frimurer, 2003, Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities, Biophys. J., 84, 2273, 10.1016/S0006-3495(03)75033-4 Garcia-Beltran, 2021, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, Cell, 184, 2372, 10.1016/j.cell.2021.03.013 Glowacka, 2011, Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J. Virol., 85, 4122, 10.1128/JVI.02232-10 Hess, 2008, P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation, J. Chem. Theory Comput., 4, 116, 10.1021/ct700200b Hess, 1997, LINCS: a linear constraint solver for molecular simulations, J. Comput. Chem., 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Hess, 2008, GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation, J. Chem. Theory Comput., 4, 435, 10.1021/ct700301q Hoffmann, 2021, Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, EBioMedicine, 65, 103255, 10.1016/j.ebiom.2021.103255 Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Hoffmann, 2021, SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization, Cell Rep., 35, 109017, 10.1016/j.celrep.2021.109017 Hofmann-Winkler, 2020, Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation, Crit. Care Explor., 2, e0284, 10.1097/CCE.0000000000000284 Huang, 2020, Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19, Acta Pharmacol. Sin., 41, 1141, 10.1038/s41401-020-0485-4 Iwata-Yoshikawa, 2019, TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection, J. Virol., 93, 10.1128/JVI.01815-18 Izaguirre, 2001, Langevin stabilization of molecular dynamics, J. Chem. Phys., 114, 2090, 10.1063/1.1332996 Jones, 1997, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol., 267, 727, 10.1006/jmbi.1996.0897 Kannan, 2021, Evolving biothreat of variant SARS-CoV-2–molecular properties, virulence and epidemiology, Eur. Rev. Med. Pharmacol. Sci., 25, 4405 Kawase, 2012, Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry, J. Virol., 86, 6537, 10.1128/JVI.00094-12 Kim, 2016, PubChem Substance and Compound databases, Nucleic Acids Res., 44, D1202, 10.1093/nar/gkv951 Kollman, 2000, Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models, Acc. Chem. Res., 33, 889, 10.1021/ar000033j Liu, 2018, Molecular dynamics simulations and novel drug discovery, Expert Opin. Drug Discov., 13, 23, 10.1080/17460441.2018.1403419 Mark, 2001, Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, J. Phys. Chem. A, 105, 9954, 10.1021/jp003020w Mark, 2002, A molecular dynamics study of tryptophan in water, J. Phys. Chem. B, 106, 9440, 10.1021/jp025965e Miller, 2012, MMPBSA. py: an efficient program for end-state free energy calculations, J. Chem. Theory Comput., 8, 3314, 10.1021/ct300418h Ni, 2020, Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19, Crit. Care, 24, 10.1186/s13054-020-03120-0 Ohshio, 1989, Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis, Gastroenterology, 96, 853, 10.1016/0016-5085(89)90912-8 Organization, W.H., 2021. COVID-19 weekly epidemiological update, 16 February 2021. Padmanabhan, 2020, Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection, PLoS Comput. Biol., 16, e1008461, 10.1371/journal.pcbi.1008461 Pettersen, 2004, UCSF Chimera–a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Pronk, 2013, GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit, Bioinformatics, 29, 845, 10.1093/bioinformatics/btt055 Ragia, 2020, Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies, Eur. J. Clin. Pharmacol., 1 Raheem, 2021, Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination: Coronavirus new Variants: effect and treatments, Baghdad J. Biochem. Appl. Biol. Sci., 2, 70, 10.47419/bjbabs.v2i02.54 Resende, 2021, A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B. 1.1. 33 circulating in Brazil, Viruses, 13, 724, 10.3390/v13050724 Rizzo, 2006, Estimation of Absolute Free Energies of Hydration Using Continuum Methods: Accuracy of Partial Charge Models and Optimization of Nonpolar Contributions, J. Chem. Theory Comput., 2, 128, 10.1021/ct050097l Rolta, 2021, Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach, Curr. Pharmacol. Rep., 7, 135, 10.1007/s40495-021-00259-4 Seeliger, 2010, Conformational transitions upon ligand binding: holo-structure prediction from apo conformations, PLoS Comput. Biol., 6, e1000634, 10.1371/journal.pcbi.1000634 Shang, 2020, Cell entry mechanisms of SARS-CoV-2, Proc. Natl. Acad. Sci., 117, 11727, 10.1073/pnas.2003138117 Shen, 2021, SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines, Cell Host Microbe, 29, 10.1016/j.chom.2021.03.002 Still, 1990, Semianalytical treatment of solvation for molecular mechanics and dynamics, J. Am. Chem. Soc., 112, 6127, 10.1021/ja00172a038 Tang, 2020, Coronavirus membrane fusion mechanism offers a potential target for antiviral development, Antiviral Res., 178, 104792, 10.1016/j.antiviral.2020.104792 Tateyama-Makino, 2021, The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2 in vitro, PLoS ONE, 16, e0257705, 10.1371/journal.pone.0257705 Tian, 2021, The global epidemic of SARS-CoV-2 variants and their mutational immune escape, J. Med. Virol. Uno, 2020, Camostat mesilate therapy for COVID-19, Intern. Emerg. Med., 15, 1577, 10.1007/s11739-020-02345-9 Wang, 2021, Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization, Cell Host Microbe., 29, 747, 10.1016/j.chom.2021.04.007 Xiong, 2021, ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Res., 49, W5, 10.1093/nar/gkab255 Zamorano Cuervo, 2020, ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities, Elife, 9, 10.7554/eLife.61390 Zhou, 2015, Protease inhibitors targeting coronavirus and filovirus entry, Antiviral Res., 116, 76, 10.1016/j.antiviral.2015.01.011